Now showing items 1-1 of 1

    • CDK4/6 Inhibitors: Promising Opportunities beyond Breast Cancer. 

      Lim, JS; Turner, NC; Yap, TA (2016-07)
      Patnaik and colleagues report on the safety, pharmacokinetics, pharmacodynamics, and preliminary efficacy of abemaciclib for the treatment of advanced solid cancers, demonstrating antitumor activity in advanced breast ...